Remove COVID-19 Remove Heart Disease Remove Kidney Disease
article thumbnail

Predictors of worse outcome after postponing non-emergency cardiac interventions during the COVID-19 pandemic

Open Heart

Methods This observational case-control study included consecutive patients whose non-emergency cardiac intervention has been postponed during COVID-19-related lockdown between 19 March and 30 April 2020 (n=193). The planned intervention was deferred by a median of 23 (19–36) days. 95% CI 3.8

article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease.

article thumbnail

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease.